Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -99.4% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 5.6 | n/a |
Pr/Book | 1.5 |
Latest | F'cast | |
---|---|---|
Revenue | -14.6% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Issue of Equity and Total Voting Rights | 01-May-2024 | 17:00 | RNS |
Director/PDMR Shareholding | 01-May-2024 | 07:00 | RNS |
Publication of Annual Report and Notice of AGM | 30-Apr-2024 | 07:00 | RNS |
Oxford Nanopore tech used in 'groundbreaking' te... | 12-Apr-2024 | ShareCast |
Oxford Nanopore delays breakeven target as Covid... | 06-Mar-2024 | ShareCast |
Oxford Nanopore appoints new CFO | 22-Jan-2024 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Apr-24 | Buy | Kate Priestman | 105.54p | 23,564 | £24,869.45 |
11-Apr-24 | Transfer From | Nick Keher | 0.000p | 130 | £0.00 |
11-Apr-24 | Buy | Nick Keher | 115.00p | 130 | £149.50 |
Currency | UK Pounds |
Share Price | 111.00p |
Change Today | 0.90p |
% Change | 0.82 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 445,478 |
Shares Issued | 862.59m |
Market Cap | £957.47m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:15 | 448 @ 110.95p |
10:15 | 7 @ 110.50p |
10:14 | 3 @ 110.50p |
10:13 | 2,000 @ 110.71p |
10:12 | 2,000 @ 110.95p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research